Chief executive of AstraZeneca Pascal Soriot
Media playback is unsupported on your device

AstraZeneca boss: Pfizer bid 'will disrupt shareholders'

AstraZeneca's chief executive has said that Pfizer's proposed bid to takeover the company will be a "disruption" for staff and shareholders.

Pascal Soriot faced questioning by MPs and interested parties about the likely effect of what could be the biggest takeover of a UK company.

Go to next video: AstraZeneca Pfizer bid explained